Evidence map›Paper›PMID 32492773›Full record

ArticleFoods (Basel, Switzerland)2020

Hydrocolloid-Based Coatings with Nanoparticles and Transglutaminase Crosslinker as Innovative Strategy to Produce Healthier Fried Kobbah.

Asmaa Al-Asmar, Concetta Valeria L Giosafatto, Mohammed Sabbah, Loredana Mariniello

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Asmaa Al-AsmarDepartment of Chemical Sciences, University of Naples "Federico II", 80126 Naples, Italy.ORCID 0000-0003-0751-6301
Concetta Valeria L GiosafattoDepartment of Chemical Sciences, University of Naples "Federico II", 80126 Naples, Italy.ORCID 0000-0001-8762-2205
Mohammed SabbahDepartment of Nutrition and Food Technology, An-Najah National University, P.O. Box 7 Nablus, Palestine.ORCID 0000-0003-4631-8156
Loredana MarinielloDepartment of Chemical Sciences, University of Naples "Federico II", 80126 Naples, Italy.ORCID 0000-0002-6800-5890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study addresses the effect of coating solutions on fried kobbah. Coating solutions were made of pectin (PEC) and grass pea flour (GPF), treated or not with transglutaminase (TGase) and nanoparticles (NPs)-namely mesoporous silica NPs (MSN) or chitosan NPs (CH-NPs). Acrylamide content (ACR), water, oil content and color of uncoated (control) and coated kobbah were investigated. Zeta potential, Z-average and in vitro digestion experiments were carried out. Zeta potential of CH-NPs was stable from pH 2.0 to pH 6.0 around + 35 mV but decreasing at pH > 6.0. However, the Z-average of CH-NPs increased by increasing the pH. All coating solutions were prepared at pH 6.0. ACR of the coated kobbah with TGase-treated GPF in the presence nanoparticles (MSN or CH-NPs) was reduced by 41.0% and 47.5%, respectively. However, the PEC containing CH-NPs showed the higher reduction of the ACR by 78.0%. Water content was higher in kobbah coated by PEC + CH-NPs solutions, while the oil content was lower. The color analysis indicated that kobbah with lower browning index containing lower ACR. Finally, in vitro digestion studies of both coating solutions and coated kobbah, demonstrated that the coating solutions and kobbah made by means of TGase or nanoparticles were efficiently digested.

Indexed as

acrylamidechitosan-nanoparticlescoatingsgrass peaHPLC-RPkobbahmesoporous silica nanoparticlespectintransglutaminase

Identifiers

PMID32492773
PMCPMC7353631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.